Schedule 13D ownership disclosure
ZIVO BIOSCIENCE
Common Stock, par value $.001 per share · CUSIP: 98978N101
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Mark E. StromeReported CIK 0000919484
Shares: 472,942.00 · Class: 12.10%
- Strome Group, Inc.Reported CIK 0001355526
Shares: 278,639.00 · Class: 7.13%
- Strome Investment Management, LPReported CIK 0000936711
Shares: 278,639.00 · Class: 7.13%
- Strome Mezzanine Fund, LPReported CIK 0001713153
Shares: 0.00 · Class: 0%
- Strome Mezzanine Fund II, LPReported CIK 0001978360
Shares: 266,198.00 · Class: 6.81%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-26-021894
- Form type
- SCHEDULE 13D/A
- Filer
- STROME MARK E
- CIK
- CIK 919484
- Filed
- Feb 27, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13D beneficial ownership